Concepedia

Pieter L. Jager

PL

Statistics

Publications

81

Citations

4.9K

H-Index

39

Active since

2000

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Isala

University of Twente

Leiden University Medical Center

Pieter L. Jager is an author at University Medical Center Groningen specializing in medicine, nuclear medicine, and oncology.

Publications per year

2000–2023

81

Publications

81

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2006 · 308 citations · Full text

, , +17

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

Aren van Waarde, D. Cobben, Albert J.H. Suurmeijer et al. · PubMed · 2004 · 267 citations · Full text

, , +17

Improved Staging of Patients With Carcinoid and Islet Cell Tumors With <sup>18</sup>F-Dihydroxy-Phenyl-Alanine and <sup>11</sup>C-5-Hydroxy-Tryptophan Positron Emission Tomography

Klaas Pieter Koopmans, Oliver Neels, Ido P. Kema et al. · Journal of Clinical Oncology · 2008 · 238 citations · Full text

, , +17

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

Klaas Pieter Koopmans, Elisabeth G.E. de Vries, Ido P. Kema et al. · The Lancet Oncology · 2006 · 234 citations

, , +15

Preclinical characterisation of <sup>111</sup>In‐DTPA‐trastuzumab

Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik et al. · British Journal of Pharmacology · 2004 · 177 citations · Full text

, , +17

1–5 of 81